Exploring Cholinergic Compounds for Peripheral Neuropathic Pain Management: A Comprehensive Scoping Review of Rodent Model Studies - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) Pharmaceuticals Année : 2023

Exploring Cholinergic Compounds for Peripheral Neuropathic Pain Management: A Comprehensive Scoping Review of Rodent Model Studies

Edouard Montigné
  • Fonction : Auteur
  • PersonId : 1308273
David Balayssac

Résumé

Neuropathic pain affects about 7–8% of the population, and its management still poses challenges with unmet needs. Over the past decades, researchers have explored the cholinergic system (muscarinic and nicotinic acetylcholine receptors: mAChR and nAChR) and compounds targeting these receptors as potential analgesics for neuropathic pain management. This scoping review aims to provide an overview of studies on peripheral neuropathic pain (PNP) in rodent models, exploring compounds targeting cholinergic neurotransmission. The inclusion criteria were original articles on PNP in rodent models that explored the use of compounds directly targeting cholinergic neurotransmission and reported results of nociceptive behavioral assays. The literature search was performed in the PubMed and Web of Science databases (1 January 2000–22 April 2023). The selection process yielded 82 publications, encompassing 62 compounds. The most studied compounds were agonists of α4β2 nAChR and α7 nAChR, and antagonists of α9/α10 nAChR, along with those increasing acetylcholine and targeting mAChRs. Studies mainly reported antinociceptive effects in traumatic PNP models, and to a lesser extent, chemotherapy-induced neuropathy or diabetic models. These preclinical studies underscore the considerable potential of cholinergic compounds in the management of PNP, warranting the initiation of clinical trials.
Fichier principal
Vignette du fichier
Exploring Cholinergic Compounds for Peripheral Neuropathic Pain Management.pdf (845.71 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Licence : CC BY - Paternité

Dates et versions

hal-04285363 , version 1 (14-11-2023)

Licence

Paternité

Identifiants

Citer

Edouard Montigné, David Balayssac. Exploring Cholinergic Compounds for Peripheral Neuropathic Pain Management: A Comprehensive Scoping Review of Rodent Model Studies. Pharmaceuticals, 2023, 16 (10), pp.1363. ⟨10.3390/ph16101363⟩. ⟨hal-04285363⟩

Collections

PRES_CLERMONT ND
12 Consultations
19 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More